LINCOLN, Neb. (KOLN) - Visit Nebraska announced Monday the stops included in the 2026 Nebraska Passport program. This annual challenge helps residents and out-of-state visitors travel and discover the ...

Moderna said on Wednesday the U.S. drug regulator will review its modified flu vaccine application, a week after rejecting the original submission and fueling industry concerns over shifts in the ...

Moderna said today the Food and Drug Administration changed course and will review an amended application for its new flu vaccine, a week after rejecting the original submission and fueling drugmaker ...

Congress has voted to advance the SAVE Act, an election bill that would require proof of citizenship to register to vote and photo identification to cast a ballot. And though it faces stiff opposition ...

During the COVID-19 pandemic, President Donald Trump then described mRNA technology as a "modern-day miracle." HealthDay News — In a major blow to vaccine development, the US Food and Drug ...

The Food and Drug Administration has refused to review Moderna's application for its seasonal flu vaccine, the company announced on Feb. 10, marking the latest setback for the development of ...

The Food and Drug Administration has refused to review an application from the biotech company Moderna to approve its mRNA-based flu vaccine. The agency's decision, which Moderna announced in a press ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Ana Santos Rutschman, Villanova University (THE CONVERSATION) The Food and Drug ...

The Food and Drug Administration (FDA) has refused to review an application by Moderna for its influenza mRNA vaccine, not due to issues with the shot itself but what the agency claims was substandard ...

Add Yahoo as a preferred source to see more of our stories on Google. Moderna said the FDA's refusal was inconsistent with previous feedback from the agency. - Graham Hughes/Bloomberg/Getty Images The ...

WASHINGTON (AP) — The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday ...